Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexJagath R. Junutula, William Mallet, Chien C Lee et al.|Nature Biotechnology|2008Cited by 1.4k
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variantsNga Bien‐Ly, Ryan J. Watts, Yang Yu et al.|The Journal of Experimental Medicine|2014Cited by 353
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesY. Joy Yu Zuchero, Ryan J. Watts, Xiaocheng Chen et al.|Neuron|2015Cited by 292
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( <u>Part 3</u> –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)Bart Corsaro, Meina Liang, Tong‐Yuan Yang et al.|Bioanalysis|2021Cited by 60
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)LiNa Loo, Robert Kubiak, Shannon Harris et al.|Bioanalysis|2022Cited by 35